Imms, C., Wallen, M., Elliott, C., Hoare, B., Randall, M. J, Greaves, S., Adair, B., Bradshaw, E., Carter, R., Orsini, F., Shih, S. T & Reddihough, DS. (2016). Minimising impariment: Protocol for a multicentre randomised controlled trial of upper limb orthoses for children with cerebral palsy. BMC Pediatrics,16(70), 1-15. United Kingdom: BioMed Central Ltd. Retrieved from https://doi.org/10.1186/s12887-016-0608-8
Background: Upper limb orthoses are frequently prescribed for children with cerebral palsy ( CP ) who have muscle overactivity predominantly due to spasticity, with little evidence of long-term effectiveness. Clinical consensus is that orthoses help to preserve range of movement: nevertheless, they can be complex to construct, expensive, uncomfortable and require commitment from parents and children to wear. This protocol paper describes a randomised controlled trial to evaluate whether long-term use of rigid wrist/hand orthoses ( WHO ) in children with CP, combined with usual multidisciplinary care, can prevent or reduce musculoskeletal impairments, including muscle stiffness/tone and loss of movement range, compared to usual multidisciplinary care alone. Methods/design: This pragmatic, multicentre, assessor-blinded randomised controlled trial with economic analysis will recruit 194 children with CP, aged 5–15 years, who present with flexor muscle stiffness of the wrist and/or fingers/thumb ( Modified Ashworth Scale score ≥1 ). Children, recruited from treatment centres in Victoria, New South Wales and Western Australia, will be randomised to groups ( 1:1 allocation ) using concealed procedures. All children will receive care typically provided by their treating organisation. The treatment group will receive a custom-made serially adjustable rigid WHO, prescribed for 6 h nightly ( or daily ) to wear for 3 years. An application developed for mobile devices will monitor WHO wearing time and adverse events. The control group will not receive a WHO, and will cease wearing one if previously prescribed. Outcomes will be measured 6 monthly over a period of 3 years. The primary outcome is passive range of wrist extension, measured with fingers extended using a goniometer at 3 years. Secondary outcomes include muscle stiffness, spasticity, pain, grip strength and hand deformity. Activity, participation, quality of life, cost and cost-effectiveness will also be assessed. Discussion: This study will provide evidence to inform clinicians, services, funding agencies and parents/carers of children with CP whether the provision of a rigid WHO to reduce upper limb impairment, in combination with usual multidisciplinary care, is worth the effort and costs. Trial registration: ANZ Clinical Trials Registry: U1111-1164-0572.
Open Access Journal Article